Dr. Schwartz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8042 wurzbach suite 420
San Antonio, TX 78229Phone+1 210-949-0807
Education & Training
Rush University Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1976 - 1977
Michael Reese Hospital and Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1975 - 1976- Michael Reese Hospital and Medical CenterResidency, Internal Medicine, 1972 - 1975
University of Illinois College of MedicineClass of 1972
Certifications & Licensure
CA State Medical License 1977 - Present
IL State Medical License 1973 - Present
TX State Medical License 1977 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
- Top MD Consumers Checkbook
Clinical Trials
- Safety and Efficacy of PEG-Encapsulated Islet Allografts Implanted in Type I Diabetic Recipients Start of enrollment: 2005 Nov 01
- The Effect of Betahistine on Body Weight in Obese Subjects Start of enrollment: 2007 Jan 01
- Safety and Tolerability Study of MBX-2044 in Patients With Type 2 Diabetes Start of enrollment: 2006 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- Non-alcoholic Steatohepatitis: From Pathophysiology to Clinical PracticeSherwyn Schwartz, Jean Lucas, Mark H DeLegge, Iqvia, Raleigh, Nc, Usa
Touchreviews in Endocrinology. 2021-01-01 - 1 citationsPlasma glucose and insulin response to two oral nutrition supplements in adults with type 2 diabetes mellitus.Maureen B. Huhmann, Kristen N Smith, Sherwyn L Schwartz, Stacie K Haller, Sarah R. Irvin
BMJ Open Diabetes Research & Care. 2016-08-01 - 29 citationsA pooled analysis evaluating the efficacy and tolerability of tapentadol extended release for chronic, painful diabetic peripheral neuropathy.Sherwyn Schwartz, Mila Etropolski, Douglas Y. Shapiro, C. Rauschkolb, Aaron I. Vinik
Clinical Drug Investigation. 2015-02-01
Press Mentions
How a New COVID Vaccine Type Could Eliminate the Need for BoostersNovember 22nd, 2022- More San Antonio Hispanics Need to Participate in Coronavirus Vaccine Trials, Officials UrgeDecember 6th, 2020
Effect of Alendronate and MK-677 (A Growth Hormone Secretagogue), Individually and in Combination, on Markers of Bone Turnover and Bone Mineral Density in Postmenopausal Osteoporotic WomenJuly 22nd, 2020- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
